BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34967557)

  • 21. Tobacco companies' use of retailer incentives after a ban on point-of-sale tobacco displays in Scotland.
    Stead M; Eadie D; Purves RI; Moodie C; Haw S
    Tob Control; 2018 Jul; 27(4):414-419. PubMed ID: 28760911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cigarette pricing 1 year after new restrictions on tobacco industry retailer programmes in Quebec, Canada.
    Callard CD; Collishaw N
    Tob Control; 2019 Sep; 28(5):562-565. PubMed ID: 30770437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New frontier, new power: the retail environment in Australia's dark market.
    Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii95-101. PubMed ID: 14645954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Gone are the days of mass-media marketing plans and short term customer relationships": tobacco industry direct mail and database marketing strategies.
    Lewis MJ; Ling PM
    Tob Control; 2016 Jul; 25(4):430-6. PubMed ID: 26243810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marketing IQOS in a dark market.
    Mathers A; Schwartz R; O'Connor S; Fung M; Diemert L
    Tob Control; 2019 Mar; 28(2):237-238. PubMed ID: 29724866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing Disparities in Tobacco Retailer Density by Banning Tobacco Product Sales Near Schools.
    Ribisl KM; Luke DA; Bohannon DL; Sorg AA; Moreland-Russell S
    Nicotine Tob Res; 2017 Feb; 19(2):239-244. PubMed ID: 27613900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Making big tobacco give in: you lose, they win.
    Wander N; Malone RE
    Am J Public Health; 2006 Nov; 96(11):2048-54. PubMed ID: 17018823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IQOS point-of-sale marketing: a comparison between Arab and Jewish neighborhoods in Israel.
    Khayat A; Levine H; Berg CJ; Abroms LC; Duan Z; Wang Y; LoParco CR; Elbaz D; Cui Y; Bar-Zeev Y
    Res Sq; 2024 Mar; ():. PubMed ID: 38464035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creating a market for IQOS: analysis of Philip Morris' strategy to introduce heated tobacco products to the Australian consumer market.
    Watts C; Burton S; Freeman B
    Tob Control; 2022 May; 31(3):458-463. PubMed ID: 33191270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Availability and Placement of Electronic Nicotine Delivery Systems at the Point-of-Sale.
    Wagoner KG; Song EY; King JL; Egan KL; Debinski B; Wolfson M; Spangler J; Sutfin EL
    Nicotine Tob Res; 2018 Jul; 20(8):1020-1024. PubMed ID: 29059443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two tobacco retailer programmes in Banyuwangi, Indonesia: a qualitative study.
    Azzahro EA; Dewi DMSK; Puspikawati SI; Handayani RP; Ayodya G; Prayogi ARY; Sebayang SK
    Tob Control; 2021 Mar; ():. PubMed ID: 33685993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transferring Racial/Ethnic Marketing Strategies From Tobacco to Food Corporations: Philip Morris and Kraft General Foods.
    Nguyen KH; Glantz SA; Palmer CN; Schmidt LA
    Am J Public Health; 2020 Mar; 110(3):329-336. PubMed ID: 31944842
    [No Abstract]   [Full Text] [Related]  

  • 33. Thailand--lighting up a dark market: British American tobacco, sports sponsorship and the circumvention of legislation.
    MacKenzie R; Collin J; Sriwongcharoen K
    J Epidemiol Community Health; 2007 Jan; 61(1):28-33. PubMed ID: 17183011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Keep it a secret": leaked documents suggest Philip Morris International, and its Japanese affiliate, continue to exploit science for profit.
    Braznell S; Laurence L; Fitzpatrick I; Gilmore AB
    Nicotine Tob Res; 2024 Jun; ():. PubMed ID: 38925638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How Philip Morris unlocked the Japanese cigarette market: lessons for global tobacco control.
    Lambert A; Sargent JD; Glantz SA; Ling PM
    Tob Control; 2004 Dec; 13(4):379-87. PubMed ID: 15564622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defending strong tobacco packaging and labelling regulations in Uruguay: transnational tobacco control network versus Philip Morris International.
    Crosbie E; Sosa P; Glantz SA
    Tob Control; 2018 Mar; 27(2):185-194. PubMed ID: 28336521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a Youth-Engaging Intervention on Illegal Sales by Tobacco Retailers Near Schools in Thailand.
    Phetphum C; Noosorn N
    Asia Pac J Public Health; 2020; 32(6-7):340-345. PubMed ID: 32698607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploiting a low tax system: non-tax-induced cigarette price increases in Taiwan 2011-2016.
    Gao W; Sanna M; Branston JR; Chiou HY; Chen YH; Wu A; Wen CP
    Tob Control; 2019 Dec; 28(e2):e126-e132. PubMed ID: 31164488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Building tobacco control research in Thailand: meeting the need for innovative change in Asia.
    Hamann SL; Mock J; Hense S; Charoenca N; Kungskulniti N
    Health Res Policy Syst; 2012 Jan; 10():3. PubMed ID: 22284811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.